Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Neurobiol Aging. 2009 Dec 16;32(11):2030–2044. doi: 10.1016/j.neurobiolaging.2009.11.022

Figure 4. CX3CR1 blocking antibody increases hippocampal IL-1β levels.

Figure 4

In 3 month old male rats treated for 28 days with the blocking antibody we found a significant increase in IL-1β protein levels compared to non-immune IgG or saline control animals. (††p=0.0023 saline vs. IgG) (***p=0.0003 saline vs. α-CX3CR1) (*p=0.039 IgG vs. α-CX3CR1) (Saline n=8; IgG n=4; α-CX3CR1 n=5).